β-cell regeneration to treat Type 1 diabetes mellitus

References

• American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care27(Suppl. I), S5–S10 (2004).
   PubMedGoogle Scholar
• Wild S, Roglic G, Green A et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care27(5), 1047–1053 (2004).
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab. Res. Rev.15(3), 205–218 (1999).
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.329(14), 977–986 (1993).
   PubMed Web of Science ®Google Scholar
• Marshall AL, Chetwynd A, Morris JA et al. Type 1 diabetes mellitus in childhood: a matched case control study in Lancashire and Cumbria, UK. Diabet. Med.21(9), 1035–1040 (2004).
   Google Scholar
• Notkins AL, Lernmark A. Autoimmune Type 1 diabetes: resolved and unresolved issues. J. Clin. Invest.108(9), 1247–1252 (2001).
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Di Mario U. Autoimune diabetes not requiring insulin at diagnosis (latent autoimune diabetes of the adult). Diabetes Care24(8), 1460–1467 (2001).
   PubMed Web of Science ®Google Scholar
• Palmer JP, Fleming GA, Greenbaum CJ et al. C-peptide is the appropriate outcome measure for Type 1 diabetes clinical trials to preserve β-cell function. Diabetes53(1), 250–264 (2004).
   PubMedGoogle Scholar
• Redondo MJ, Rewers M, Yu L et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with Type 1A diabetes: prospective twin study. BMJ318(7319), 698–702 (1999).
   PubMedGoogle Scholar
• Bennett ST, Todd JA. Human Type 1A diabetes and the insulin gene: principles of mapping polygenes. Annu. Rev. Genet.30, 343–370 (1996).
   PubMed Web of Science ®Google Scholar
• Fairweather D L, Rose NR. Type 1 diabetes: virus infection or autoimmune disease? Nat. Immunol.3(4), 383–340 (2002).
   Google Scholar
• Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ328(7442), 750–754 (2004).
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Mandrup-Poulsen T. A choice of death: the signal transduction of immune-mediated β-cell apoptosis. Diabetologia44, 2115–2133 (2001).
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Kutlu B, Rasschaert J, Darville M, Cardozo AK. Use of microarray analysis to unveil transcription factor and gene networks contributing to β-cell dysfunction and apoptosis. Ann. NY Acad. Sci.1005, 55–74 (2003).
   PubMed Web of Science ®Google Scholar
• Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic β-cell death in Type 1 and Type 2 diabetes: many differences, few similarities. Diabetes54(Suppl. 2), S97–S107 (2005).
   PubMed Web of Science ®Google Scholar
• The Epidemiology of Diabetes Interventions and Complications Research Group. The effect of intensive insulin therapy on the microvascular complications of Type 1 diabetes mellitus. JAMA287(19), 2563–2569 (2002).
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual β-cell function in patients with Type 1 diabetes in the Diabetes Control and Complications Trial. Ann. Intern. Med.128(7), 517–523 (1998).
   PubMed Web of Science ®Google Scholar
• Couri CE, Foss MC, Voltarelli JC. Secondary prevention of Type 1 diabetes mellitus: stopping immune destruction and promoting β-cell regeneration. Braz. J. Med. Biol. Res.39(10), 1271–1280 (2006).
   Google Scholar
• Elliott RB, Berryman CC, Crossley JR, James AG. Partial preservation of pancreatic β-cell function in children with diabetes. Lancet19(2), 631–632 (1981).
   Google Scholar
• Harrison LC, Colman PG, Dean B, Baxter R, Martin FI. Increased in remission rate in newly diagnosed Type l diabetic subjects treated with azathioprine. Diabetes34(12), 1306–1308 (1985).
   PubMed Web of Science ®Google Scholar
• Cook JJ, Hudson I, Harrison LC et al. Double-blind controlled trial of azathioprine in children with newly diagnosed Type I diabetes. Diabetes38(6), 779–783 (1989).
   PubMed Web of Science ®Google Scholar
• Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Jonhson S. Immunosupression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N. Engl. J. Med.319(10), 599–604 (1988).
   PubMed Web of Science ®Google Scholar
• Assan R, Feutren G, Sirmai J et al. Plasma C-peptide levels and clinical remissions in recent-onset Type 1 diabetic patients treated with cyclosporin A and insulin. Diabetes39(7), 768–774 (1990).
   PubMed Web of Science ®Google Scholar
• Bougnères F, Landais P, Boisson C et al. Limited duration of remission of insulin dependency in children with recent overt Type I diabetes treated with low-dose cyclosporin. Diabetes39(10), 1264–1272 (1990).
   PubMed Web of Science ®Google Scholar
• Herold KC, Hagopian W, Auger JA et al. Anti-CD3 monoclonal antibodiy in new-onset Type 1 diabetes mellitus. N. Engl. J. Med.346(22), 1692–1698 (2002).
   PubMed Web of Science ®Google Scholar
• Keymeulen B, Vandemeulebroucke E, Ziegler AG et al. Insulin needs after CD3-antibody therapy in new-onset Type 1 diabetes. N. Engl. J. Med.352(25), 2598–2608 (2005).
   PubMed Web of Science ®Google Scholar
• Raz I, Elias D, Avron A, Metzger M, Cohen IR. β-cell function in newly-onset Type 1 diabetes and immunomodulation with a heat shock protein peptide (DiaPep277): a randomised, double-blind, Phase II trial. Lancet358(9295), 1749–1753 (2001).
   PubMed Web of Science ®Google Scholar
• Saudek F, Havrdova T, Boucek P, Novota P, Skibova J. Polyclonal anti-T-cell therapy for Type 1 diabetes mellitus of recent onset. Rev. Diabet. Stud.1(2), 80–88 (2004).
   PubMedGoogle Scholar
• Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood99(3), 768–784 (2002).
   PubMed Web of Science ®Google Scholar
• Burt RK, Traynor A, Statkute L et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA295(5), 527–535 (2006).
   PubMed Web of Science ®Google Scholar
• Voltarelli JC, Couri CEB, Stracieri ABPL et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed Type 1 diabetes mellitus. JAMA297(14), 1568–1576 (2007).
   PubMed Web of Science ®Google Scholar
• Voltarelli JC, Burt RK, Kenyon N, Kaufman DB, Squiers E. Hematopoietic stem cell transplantation as treatment for Type 1 diabetes. In: Stem Cell Therapy for Autoimmmune Diseases. Burt R, Marmont A (Eds). Landes Bioscience TX, USA, 442–447 (2004).
   Google Scholar
• European Nicotinamide Diabetes Intervention Trial Group: European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of Type 1 diabetes. Lancet363(9413), 925–931 (2004).
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Trial – Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with Type 1 diabetes mellitus. N. Engl. J. Med.346(22), 1685–1691 (2002).
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Trial – Type 1 Study Group. Effects of oral insulin in relatives of patients with Type 1 diabetes. Diabetes Care28(5), 1068–1076 (2005).
   PubMed Web of Science ®Google Scholar
• Nakayama M, Abiru N, Moriyama H et al. Prime role for an insulin epitope in the development of Type 1 diabetes in NOD mice. Nature435, 220–223 (2005).
   PubMed Web of Science ®Google Scholar
• Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of Type 1 diabetes: a birth-cohort study. Lancet358(9292), 1500–1503 (2004).
   Google Scholar
• Staeva-Vieira T, Peakman M, von Herrath M. Translational mini-review series on Type 1 diabetes: immune-based therapeutic approaches for Type 1 diabetes. Clin. Exp. Immunol.148, 17–31 (2007).
   PubMed Web of Science ®Google Scholar
• Bonner-Weir S, Sharma A. Pancreatic stem cell. J. Pathol.197(4), 519–526 (2002).
   PubMed Web of Science ®Google Scholar
• Swenne I. Pancreatic β-cell growth and diabetes mellitus. Diabetologia35(3), 193–201 (1992).
   PubMed Web of Science ®Google Scholar
• Fernandes A, King LC, Guz Y, Stein R, Wright CV, Teitelman G. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology138(4), 1750–1762 (1997).
   PubMed Web of Science ®Google Scholar
• Finegood DT, Scaglia R, Bonner-Weir S. Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes44(3), 249–256 (1995).
   PubMed Web of Science ®Google Scholar
• Kuroda A, Yamasaki Y, Imagawa A. β-cell regeneration in a patient with Type 1 diabetes mellitus who was receiving immunosuppressive therapy. Ann. Intern. Med.139(10), 81 (2003).
   PubMedGoogle Scholar
• Fischbach GD, Fischbach RL. Stem cells: science, policy and ethics. J. Clin. Invest.114(10), 1364–1370 (2004).
   PubMed Web of Science ®Google Scholar
• Wagers AJ, Weissman IL. Plasticity of adults stem cells. Cell116(5), 639–648 (2004).
   PubMed Web of Science ®Google Scholar
• Seaberg R, Smukler SR, Kieffer TJ et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol.22(9), 1115–1124 (2004).
   PubMed Web of Science ®Google Scholar
• Georgia S, Blushan A. β cell replication is the primary mechanism of maintaining postnatal β cell mass. J. Clin. Invest.114(7), 963–968 (2004).
   PubMed Web of Science ®Google Scholar
• Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature429(6987), 41–46 (2004).
   PubMed Web of Science ®Google Scholar
• Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by β cell regeneration. J. Clin. Invest.117(9), 2553–2561 (2007).
   PubMed Web of Science ®Google Scholar
• Suzuki A, Nakauchi H, Tanigichi H. Prospective isolation of pancreatic multipotent progenitors using flow-cytometric cell sorting. Diabetes53(8), 2143–2152 (2004).
   PubMedGoogle Scholar
• Noguchi Y, Nakajima-Yamada T, Yamada K et al. R-130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models. Eur. J. Pharmacol.506(3), 285–295 (2005).
   Google Scholar
• Bonner-Weir S, Taneja M, Weir GC et al.In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl Acad. Sci. USA97(14), 7999–8004 (2000).
   PubMed Web of Science ®Google Scholar
• Lechner A, Habener JF. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am. J. Physiol. Endocrinol. Metab.284(2), E259–E266 (2003).
   Google Scholar
• Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest.111(6), 843–850 (2003).
   PubMed Web of Science ®Google Scholar
• Choi JB, Uchino H, Azuma K et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic β cells. Diabetologia46(10), 1366–1374 (2003).
   PubMed Web of Science ®Google Scholar
• Hess D, Li L, Martin M et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol.21, 763–770 (2003).
   PubMed Web of Science ®Google Scholar
• Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic β-cell injury. Diabetes53, 91–98 (2004).
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Ogihara T, Yamada T et al. Bone marrow (BM) transplantation promotes β-cell regeneration after acute injury through BM cell mobilization. Endocrinology148, 2006–2015 (2007).
   PubMed Web of Science ®Google Scholar
• Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cell can differentiate into hepatocytes in vivo. Nat. Med.6(11), 1229–1234 (2000).
   PubMed Web of Science ®Google Scholar
• Theise ND, Badve S, Saxena R et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology,31(1), 235–240 (2000).
   PubMed Web of Science ®Google Scholar
• Kang EM, Zickler MM, Burns S et al. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp. Hematol.33(6), 699–705 (2005).
   PubMedGoogle Scholar
• Butler AE, Huang A, Rao PN et al. Hematopoietic stem cells derived from adult donors are not a source of pancreatic β-cells in adult nondiabetic humans. Diabetes56(7), 1810–1816 (2007).
   Google Scholar
• Nelson JL, Torres I, Louie FM et al. Pre-existing autoimmune diseasein patients with long term survival after allogeneic bone marrow transplantation. J. Rheumatol.24(48), 23–29 (1997).
   Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult bone marrow. Nature418(6893), 41–49 (2002).
   PubMed Web of Science ®Google Scholar
• Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet β-cells. World J. Gastroenterol.10(20), 3016–3020 (2004).
   PubMed Web of Science ®Google Scholar
• Tang DQ, Cao LZ, Burkhardt BR et al.In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes53(7), 1721–1732 (2004).
   PubMed Web of Science ®Google Scholar
• Lee HR, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl Acad. Sci. USA103(46), 17438–17443 (2006).
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen L, Hou XG et al. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin. Med. J. (Engl.)120(9), 771–776 (2007).
   PubMed Web of Science ®Google Scholar
• Timper K, Seboek D, Eberhardt M et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagons expressing cells. Biochem. Biophys. Res. Commun.341(4), 1155–1160 (2006).
   Google Scholar
• Ruhnke M, Ungefroren H, Nussler et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology128(7), 1774–1786 (2005).
   PubMed Web of Science ®Google Scholar
• Tuma-Mubarak J, Fernandez-Viña R, Yalan AC et al. Autologous bone marrow mononuclear cell (ABMMC) transplantation in Type 1 and Type 2 insulin-dependent diabetes mellitus patients. International Society of Cell Therapy Meeting. Sydney, Australia 24–27 June (2007).
   Google Scholar
• Novoa JE, Medina MA, Gordillo F et al. The Conzi’s effect in human diabetes mellitus: from bone marrow progenitor cells (BMPCs) to β cells. Archivos de Medicina Interna1(Suppl. 1), 34 (2007).
   Google Scholar
• Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in Type 1 diabetic mice. Biochem. Biophys. Res. Commun.325(3), 665–669 (2004).
   PubMed Web of Science ®Google Scholar
• Ende N, Chen R, Reddi AS. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in Type 2 diabetic mice. Biochem. Biophys. Res. Commun.321(1), 168–71 (2004).
   PubMed Web of Science ®Google Scholar
• Naruse K, Hamada Y, Nakashima E et al. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes54(6), 1823–1828 (2005).
   PubMed Web of Science ®Google Scholar
• Haller MJ, Viener HL, Brusko T et al. Insulin requirements, HbA1c, and stimulated C-peptide following autologous umbilical cord blood transfusion in children with T1D. Abstracts ADA 67th Scientific Sessions. A82 (2007).
   Google Scholar
• Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology27(2), 433–445 (1998).
   PubMed Web of Science ®Google Scholar
• Yang L, Li S, Hatch H et al.in vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl Acad. Sci. USA99(12), 8078–8083 (2002).
   PubMed Web of Science ®Google Scholar
• Kim S, Shin JS, Kim HJ, Fisher RC, Lee MJ, Kim CW. Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration. Lab. Invest.87(7), 702–712 (2007).
   Web of Science ®Google Scholar
• Assady S, Maor G, Amit M, Itskovitzs-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes50(8), 1691–1697 (2001).
   PubMed Web of Science ®Google Scholar
• Soria B, Roche E, Berna G, Leon-Quito T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes49(2), 157–162 (2000).
   PubMed Web of Science ®Google Scholar
• Hansson M, Tonning A, Frandsen U et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes53(10), 2603–2609 (2004).
   PubMed Web of Science ®Google Scholar
• Jaenisch R. Human cloning – the science and ethics of nuclear transplantation. N. Engl. J. Med.351(27), 2787–2791 (2004).
   PubMed Web of Science ®Google Scholar
• Chong S, Normile D. Stem cells. How young Korean researchers helped unearth a scandal. Science311(5757), 22–25 (2006).
   PubMed Web of Science ®Google Scholar
• Smykodub OI, Noritskaya AV. Embryonic stem cells in new onset Type 2 diabetes mellitus. Cytotherapy6(4), 402 (2004).
   Google Scholar
• Smykodub OI, Noritskaya AV. Embryonic stem cells in pernicious decompensated Type 2 diabetes mellitus. Cytotherapy6(4), 402 (2004).
   Google Scholar
• Sinden JD. ReNeuron Group plc. Regenerative Med.1(1), 143–147 (2006).
   Google Scholar
• Colman A, Alliston D. ES Cell International and regenerative medicine. Regenerative Med.1(2), 287–292 (2006).
   Google Scholar
• Bresson D, von Herrath M. Moving towards efficient therapies in Type 1 diabetes: to combine or not to combine? Autoimmune Rev.6(5), 315–322 (2007).
   PubMed Web of Science ®Google Scholar